ARCHIVES

Clinical Biomarker Discovery Initiative would speed progress in early detection and measurement of response to therapy, Leland Hartwell tells NCI.

This article is from The Cancer Letter archive.

Vol. 30 No. 43 | November 12, 2004

Download PDF Visit The Full Archive

Related Articles

Capitol Hill: Bills Seeks Coverage for Treatment Of cancers Found in CDC Screening

April 2, 1999

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

October 17, 2014

NCI Cooperative Group Clinical Trials Approved

July 31, 2009

NIH Review Division Considering Proposal For Clinical Oncology Study Section

October 10, 1997

NCCS Networker Volume 11 Issue 2, Summer 1997

June 13, 1997

Califano Insists On Search Committee To Look for NCI Chief; Brown Still In Running

February 25, 1977